Roth Capital Initiates Coverage on Alphatec Holdings (ATEC) with a Buy
Roth Capital initiates coverage on Alphatec Holdings (Nasdaq: ATEC) with a Buy. Price target $7.
To see more analyst ratings on ATEC Click Here.
Alphatec Holdings, Inc., through its wholly owned subsidiary, Alphatec Spine, Inc., designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine.
Related Categories
New CoverageStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
